The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE condemns Iranian attack on Kuwait
UAE offers condolences after deadly South Africa bus crash
UAE launches annual award to honour changemakers
UAE becomes second country to approve Lipfendra to treat high cholesterol
Sharjah Police recovers AED 500,000 in stolen goods in under 3 hours
UAE welcomes Gaza agreement for Hamas disarmament
Sheikh Abdullah meets UK Foreign Secretary in London
H.H. Sheikh Hamdan attends GCC joint military drill in Bahrain
